Grifols has dosed the first participant in a Phase 3 [...]

Resalis Therapeutics has dosed the first participant in a Phase [...]

Absci has reported positive interim Phase 1 data for ABS-201, [...]

Medicus Pharma has submitted an investigational new drug application in [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]

Patients across South Florida are set to gain greater access [...]

CNS Pharmaceuticals has reported the primary analysis of its clinical [...]

Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

Kairos Pharma, Ltd. will present positive safety and early efficacy [...]